专题：Liver Diseases and Immunity

This cluster of papers focuses on the diagnosis, management, epidemiology, and genetic factors of autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis. It also covers topics such as liver transplantation, immunosuppressive therapy, and the pathogenesis of these liver diseases.
最新文献
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

article Full Text OpenAlex

A comprehensive 26‐color immunophenotyping panel to study the role of the gut‐liver axis in chronic liver diseases

article Full Text OpenAlex

Huang Zhen mycoplasm polysaccharides mitigate nonalcoholic fatty liver disease induced by a high-fat diet in mice: Evidence from hepatic metabolomics

article Full Text OpenAlex

Fatty liver disease: time to target CCR5?

editorial Full Text OpenAlex

Risk factors of disease activity and renal damage in patients with systemic lupus erythematosus

article Full Text OpenAlex

Grading of Fatty Liver Based on Computed Tomography Hounsfield Unit Values versus Ultrasonography Grading

article Full Text OpenAlex

Diagnostic and prognostic performance of the LiverRisk score in tertiary care

article Full Text OpenAlex

Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction

editorial Full Text OpenAlex

Mechanistic study of fructus aurantii (Quzhou origin) in regulating ileal reg3g in the treatment for NASH

article Full Text OpenAlex

Evidence based treatment for lupus nephritis: present perspectives and challenges

review Full Text OpenAlex

近5年高被引文献
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

article Full Text OpenAlex 1496 FWCI205.90668394

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

article Full Text OpenAlex 1238 FWCI1139.03963808

Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management

review Full Text OpenAlex 664 FWCI82.56559329

Hepatic inflammatory responses in liver fibrosis

review Full Text OpenAlex 514 FWCI181.11690538

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease

review Full Text OpenAlex 504 FWCI68.88446634

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

article Full Text OpenAlex 479 FWCI72.08107351

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

review Full Text OpenAlex 441 FWCI65.15089093

The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer

review Full Text OpenAlex 354 FWCI27.04652534

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis

article Full Text OpenAlex 300 FWCI276.46593157

Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

review Full Text OpenAlex 299 FWCI42.00272338